Target Name: NUP210P2
NCBI ID: G100129929
Review Report on NUP210P2 Target / Biomarker Content of Review Report on NUP210P2 Target / Biomarker
Other Name(s): nucleoporin 210 pseudogene 2 | Nucleoporin 210 pseudogene 2

NUP210P2: A Potential Drug Target and Biomarker

NUP210P2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is neuropilin-210-protein, and it is a member of the neuropilin family. This protein has been shown to play a role in various physiological processes in the body, including cell signaling, neurotransmitter release, and blood pressure regulation. As a result, NUP210P2 has potential as a drug target or biomarker.

The neuropilin family consists of several proteins that are involved in the regulation of neural stem cells and the development of neural circuits. NUP210P2 is a potent inhibitor of the neuropilin-1 gene, which encodes the protein Nup210. This inhibition causes NUP210P2 to accumulate in the brain, where it can interact with the neuropilin-1 protein and disrupt its normal function.

The neuropilin-1 protein is a key regulator of the neurotransmitter release that occurs in the brain. It plays a role in the production, processing, and release of neurotransmitters, including dopamine, serotonin, and endocannabinoids. The neuropilin-1 protein is also involved in the regulation of pain perception and anxiety.

The accumulation of NUP210P2 in the brain can lead to the disruption of neurotransmitter release and a variety of physiological problems, including anxiety, depression, and pain perception. Additionally, the neuropilin-1 protein is involved in the regulation of blood pressure, and the disruption of its function can lead to hypertension.

In conclusion, NUP210P2 is a potential drug target and biomarker due to its involvement in the regulation of neurotransmitter release and blood pressure. The inhibition of NUP210P2 has been shown to cause a variety of physiological problems, including the disruption of neurotransmitter release, anxiety, depression, and pain perception. Further research is needed to fully understand the potential of NUP210P2 as a drug target or biomarker.

Protein Name: Nucleoporin 210 Pseudogene 2

The "NUP210P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUP210P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at

More Common Targets

NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1 | ODAD2 | ODAD3 | ODAD4 | ODAM | ODAPH | ODC1 | ODCP | ODF1 | ODF2 | ODF2L